Cargando…
Inhibitors of PI3K/ERK1/2/p38 MAPK Show Preferential Activity Against Endocrine-Resistant Breast Cancer Cells
Current mainstream pharmacological options for the treatment of endocrine-resistant breast cancer have limitations in terms of their side effect profile and lack of discrimination between normal and cancer cells. In the current study, we assessed the responses of normal breast epithelial cells MCF10...
Autores principales: | Khajah, Maitham A., Mathew, Princy M., Luqmani, Yunus A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841054/ https://www.ncbi.nlm.nih.gov/pubmed/28276317 http://dx.doi.org/10.3727/096504017X14883245308282 |
Ejemplares similares
-
Na(+)/K(+) ATPase activity promotes invasion of endocrine resistant breast cancer cells
por: Khajah, Maitham A., et al.
Publicado: (2018) -
Extracellular Alkaline pH Leads to Increased Metastatic Potential of Estrogen Receptor Silenced Endocrine Resistant Breast Cancer Cells
por: Khajah, Maitham A., et al.
Publicado: (2013) -
Differential Effect of Growth Factors on Invasion and Proliferation of Endocrine Resistant Breast Cancer Cells
por: Khajah, Maitham A., et al.
Publicado: (2012) -
MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell lines
por: Khajah, Maitham A., et al.
Publicado: (2022) -
Hypoxic environment may enhance migration/penetration of endocrine resistant MCF7- derived breast cancer cells through monolayers of other non-invasive cancer cells in vitro
por: Barrak, Nora H., et al.
Publicado: (2020)